Maternal SSRI treatment during offspring development results in long-term behavioral, cellular, and neuroimaging disruptions
Susan E. Maloney, Rachel M. Rahn, Shyam K. Akula, Michael A. Rieger, Katherine B. McCullough, Christine Jakes, Selma Avdagic, Krystal Chandler, Amy L. Bauernfeind, Joseph P. Culver, Joseph D. Dougherty
This study shows that maternal SSRI exposure during offspring development causes long-term behavioral, cellular, and neuroimaging disruptions, suggesting a direct role in ASD risk.
bioRxiv · Oct 18, 2017 · PreprintNeuroscience